Fidelity Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $111M | Buy |
2,306,393
+953,773
| +71% | +$41M | ﹤0.01% | 1204 |
|
|
2026
Q1 | $49.7M | Sell |
1,352,620
-8,664,705
| -86% | -$411M | ﹤0.01% | 1445 |
|
|
2025
Q4 | $510M | Sell |
10,017,325
-4,058,066
| -29% | -$208M | 0.03% | 501 |
|
|
2025
Q3 | $781M | Buy |
14,075,391
+134,231
| +1% | +$7.86M | 0.04% | 361 |
|
|
2025
Q2 | $962M | Buy |
13,941,160
+4,308,228
| +45% | +$293M | 0.05% | 286 |
|
|
2025
Q1 | $669M | Sell |
9,632,932
-388,952
| -4% | -$32.1M | 0.04% | 355 |
|
|
2024
Q4 | $862M | Sell |
10,021,884
-7,909,693
| -44% | -$855M | 0.05% | 300 |
|
|
2024
Q3 | $2.14B | Sell |
17,931,577
-1,563,065
| -8% | -$208M | 0.13% | 127 |
|
|
2024
Q2 | $2.78B | Buy |
19,494,642
+1,890,320
| +11% | +$250M | 0.18% | 82 |
|
|
2024
Q1 | $2.26B | Buy |
17,604,322
+4,941,097
| +39% | +$588M | 0.15% | 104 |
|
|
2023
Q4 | $1.31B | Buy |
12,663,225
+585,724
| +5% | +$57.9M | 0.1% | 177 |
|
|
2023
Q3 | $1.1B | Buy |
12,077,501
+1,231,727
| +11% | +$109M | 0.09% | 188 |
|
|
2023
Q2 | $878M | Buy |
10,845,774
+882,786
| +9% | +$72.1M | 0.07% | 238 |
|
|
2023
Q1 | $793M | Buy |
9,962,988
+1,623,508
| +19% | +$115M | 0.07% | 273 |
|
|
2022
Q4 | $564M | Buy |
8,339,480
+7,035,342
| +539% | +$412M | 0.06% | 344 |
|
|
2022
Q3 | $65M | Sell |
1,304,138
-101,072
| -7% | -$5.41M | 0.01% | 1135 |
|
|
2022
Q2 | $78.3M | Buy |
1,405,210
+145,142
| +12% | +$8.05M | 0.01% | 1063 |
|
|
2022
Q1 | $70M | Buy |
1,260,068
+175,564
| +16% | +$9.01M | 0.01% | 1254 |
|
|
2021
Q4 | $60.7M | Buy |
1,084,504
+133,222
| +14% | +$7.22M | ﹤0.01% | 1346 |
|
|
2021
Q3 | $45.7M | Buy |
951,282
+148,438
| +18% | +$7.18M | ﹤0.01% | 1450 |
|
|
2021
Q2 | $33.6M | Buy |
802,844
+31,716
| +4% | +$1.23M | ﹤0.01% | 1609 |
|
|
2021
Q1 | $26M | Buy |
771,128
+48,626
| +7% | +$1.73M | ﹤0.01% | 1685 |
|
|
2020
Q4 | $25.2M | Buy |
722,502
+18,204
| +3% | +$629K | ﹤0.01% | 1604 |
|
|
2020
Q3 | $24.4M | Buy |
704,298
+22,544
| +3% | +$751K | ﹤0.01% | 1487 |
|
|
2020
Q2 | $22.3M | Sell |
681,754
-223,124
| -25% | -$7.12M | ﹤0.01% | 1504 |
|
|
2020
Q1 | $27.2M | Sell |
904,878
-49,920
| -5% | -$1.49M | ﹤0.01% | 1279 |
|
|
2019
Q4 | $27.6M | Buy |
954,798
+37,606
| +4% | +$1.04M | ﹤0.01% | 1474 |
|
|
2019
Q3 | $23.7M | Sell |
917,192
-12,842
| -1% | -$325K | ﹤0.01% | 1506 |
|
|
2019
Q2 | $23.7M | Sell |
930,034
-3,685,216
| -80% | -$91.1M | ﹤0.01% | 1549 |
|
|
2019
Q1 | $121M | Sell |
4,615,250
-103,412
| -2% | -$2.54M | 0.01% | 829 |
|
|
2018
Q4 | $109M | Sell |
4,718,662
-26,792
| -0.6% | -$595K | 0.01% | 816 |
|
|
2018
Q3 | $112M | Buy |
4,745,454
+690,016
| +17% | +$16.8M | 0.01% | 904 |
|
|
2018
Q2 | $93.5M | Sell |
4,055,438
-5,427,654
| -57% | -$129M | 0.01% | 989 |
|
|
2018
Q1 | $234M | Sell |
9,483,092
-775,806
| -8% | -$20.4M | 0.03% | 620 |
|
|
2017
Q4 | $275M | Sell |
10,258,898
-384,476
| -4% | -$9.78M | 0.03% | 564 |
|
|
2017
Q3 | $256M | Sell |
10,643,374
-252,874
| -2% | -$5.71M | 0.03% | 586 |
|
|
2017
Q2 | $234M | Sell |
10,896,248
-58,242
| -0.5% | -$1.18M | 0.03% | 621 |
|
|
2017
Q1 | $188M | Sell |
10,954,490
-1,094,974
| -9% | -$19.1M | 0.02% | 717 |
|
|
2016
Q4 | $216M | Sell |
12,049,464
-5,858,678
| -33% | -$106M | 0.03% | 633 |
|
|
2016
Q3 | $372M | Sell |
17,908,142
-1,832,208
| -9% | -$45.4M | 0.05% | 419 |
|
|
2016
Q2 | $531M | Sell |
19,740,350
-183,734
| -0.9% | -$5.04M | 0.07% | 290 |
|
|
2016
Q1 | $540M | Buy |
19,924,084
+1,201,392
| +6% | +$32.2M | 0.07% | 272 |
|
|
2015
Q4 | $544M | Buy |
18,722,692
+193,066
| +1% | +$5.34M | 0.07% | 281 |
|
|
2015
Q3 | $503M | Buy |
18,529,626
+1,942,668
| +12% | +$55M | 0.07% | 299 |
|
|
2015
Q2 | $454M | Sell |
16,586,958
-2,208,048
| -12% | -$62.1M | 0.06% | 361 |
|
|
2015
Q1 | $502M | Buy |
18,795,006
+112,476
| +0.6% | +$2.59M | 0.06% | 345 |
|
|
2014
Q4 | $395M | Sell |
18,682,530
-2,234,592
| -11% | -$49.9M | 0.05% | 403 |
|
|
2014
Q3 | $498M | Sell |
20,917,122
-477,286
| -2% | -$11M | 0.07% | 319 |
|
|
2014
Q2 | $494M | Buy |
21,394,408
+1,100,912
| +5% | +$24.3M | 0.07% | 327 |
|
|
2014
Q1 | $463M | Buy |
20,293,496
+591,146
| +3% | +$12.6M | 0.06% | 334 |
|
|
2013
Q4 | $364M | Buy |
19,702,350
+3,119,260
| +19% | +$54.4M | 0.05% | 394 |
|
|
2013
Q3 | $281M | Sell |
16,583,090
-248,270
| -1% | -$4.18M | 0.04% | 474 |
|
|
2013
Q2 | $261M | Buy |
+16,831,360
| New | +$280M | 0.04% | 481 |
|
Other funds holding NVO
F
Fidelity Investments's NVO Position: Q2 2026 in Review
Fidelity Investments increased its Novo Nordisk (NVO) stake by 71% in Q2 2026, buying an estimated $41M and bringing the position to 2,306,393 shares worth $111M. The position accounts for ﹤0.01% of the portfolio, ranked #1204.
Fidelity Investments first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.78B in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Fidelity Investments held 2,306,393 shares of Novo Nordisk worth $111M as of Q2 2026.
- Fidelity Investments bought 953,773 Novo Nordisk shares in Q2 2026, an estimated $41M.
- Novo Nordisk made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1204 holding.
- Fidelity Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Fidelity Investments's Novo Nordisk position peaked at $2.78B in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.